Verastem Inc (NASDAQ:VSTM)
| 0.9408 BATS BZX Real-Time Price As of 11:43am ET |  +0.0202 / +2.19%Today’s Change | 0.90 Today|||52-Week Range 3.30 | -54.11% Year-to-Date |
Latest VSTM News | Press Releases
No recent news for Verastem Inc.
Today’s Trading
| Previous close | 0.92 |
| Today’s open | 0.93 |
| Day’s range | 0.92 - 0.95 |
| Volume | 2,691 |
| Average volume (3 months) | 1,649,937 |
| Market cap | $171.8M |
Data as of 11:43am ET, 09/27/2022
Growth & Valuation
| Earnings growth (last year) | +7.58% |
| Earnings growth (this year) | -8.29% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -96.73% |
| P/E ratio | NM |
| Price/Sales | 589.99 |
| Price/Book | 1.94 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| URGNUrogen Pharma Ltd | -0.11 | -1.38% |
| ARMPArmata Pharmaceutica... | -0.28 | -6.04% |
| VBIVVBI Vaccines Inc | +0.02 | +2.82% |
| AUTLAutolus Therapeutics... | 0.00 | 0.00% |
Data as of 11:39am ET, 09/27/2022
Financials
| Next reporting date | November 9, 2022 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $606.0K |
| Annual profit (last year) | -$71.2M |
| Net profit margin | -11,749.17% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Needham, Massachusetts |
Forecasts
